RecruitingNCT04300257

Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care


Sponsor

Kantonsspital Winterthur KSW

Enrollment

600 participants

Start Date

Oct 19, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

The primary significance of this project is to perform a detailed analysis to assess the diagnostics, treatment and follow-up care, to develop a prediction model for future patient selection regarding various diagnostic and treatment procedures.


Eligibility

Plain Language Summary

Simplified for easier understanding

This is a data registry study from the Swiss Sarcoma Network. Researchers are collecting health information from bone and soft tissue tumor patients to build a model that predicts which patients benefit most from specific treatments. **You may be eligible if...** - You have been diagnosed with a malignant (cancerous), intermediate-grade, or selected benign bone or soft tissue tumor, as classified by the Swiss Sarcoma Network - You are any age, male or female **You may NOT be eligible if...** - You have formally objected to your personal health data being used for research purposes Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(8)

Kantonsspital Winterthur

Winterthur, Canton of Zurich, Switzerland

SwissSarcomaNetwork

Winterthur, Canton of Zurich, Switzerland

Ente Ospedaliero Cantonale

Bellinzona, Canton Ticino, Switzerland

Kantonsspital Graubünden

Chur, Kanton Graubünden, Switzerland

Luzerner Kantonsspital

Lucerne, Switzerland

Pathologie Institut Enge

Zurich, Switzerland

Klinik Hirslanden

Zurich, Switzerland

Stadtspital Zürich Triemli

Zurich, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04300257


Related Trials